GlassScriptPhysician profile
Meir Salama
NPI 1588734883
$921.96
in general payments reported to CMS, 2019-2025
19 companies · $52.85 in 2025
The $52.85 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $203 · 2021: $179 · 2022: $289 · 2023: $143 · 2024: $55.78 · 2025: $52.85.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $251.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $236.73 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.00 | 2019 | |
| Ardelyx, INC. | $89.99 | 2022-2024 | Ibsrela |
| Merck Sharp & Dohme LLC | $73.34 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $67.65 | 2021-2023 | Xifaxan |
| Pfizer INC. | $41.81 | 2019 | |
| Braintree Laboratories, INC. | $36.21 | 2019 | |
| Ferring Pharmaceuticals INC. | $35.18 | 2023 | Rebyota |
| Abbvie INC. | $34.42 | 2022-2025 | |
| Ironwood Pharmaceuticals, INC | $25.00 | 2023 | Linzess |
| Daiichi Sankyo INC. | $23.90 | 2024 | Injectafer |
| Gilead Sciences, INC. | $19.68 | 2022 | |
| Novo Nordisk INC | $19.50 | 2025 | Saxenda, Wegovy |
| Exact Sciences Corporation | $17.57 | 2025 | Cologuard Collection Kit |
| Mallinckrodt Hospital Products INC. | $17.32 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celltrion USA INC. | $17.25 | 2024 | Vegzelma |
| Intra-Sana Laboratories | $16.50 | 2023 | Reltone 200 Mg, Reltone 400 Mg, Glycate |
| Redhill Biopharma INC. | $16.11 | 2022 | |
| Micro-Tech Endoscopy USA, INC. | $8.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meir Salama listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.